ELIMP: Revenue up 7.1% in Q3, EBITDA improved, and Q4 began with record sales and a product recall

Q3 saw 7.1% revenue growth, improved EBITDA, and strong B2B performance in Norway and Sweden. A product recall was initiated due to asbestos, but Q4 started with double-digit sales growth and a record new store opening in Bergen.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.